670 results on '"Lassen, Jens Flensted"'
Search Results
102. 10-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segments
103. Potential significance of spontaneous and interventional ST-changes in patients transferred for primary percutaneous coronary intervention: observations from the ST-MONitoring in Acute Myocardial Infarction study (The MONAMI study)
104. Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary percutaneous intervention
105. Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary percutanous coronary intervention
106. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort
107. Clinical outcome following late reperfusion with percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
108. Unreported exclusion and sampling bias in interpretation of randomized controlled trials in patients with STEMI
109. Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction
110. Comparison of the polymer-free biolimus-coated BioFreedom stent with the thin-strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with percutaneous coronary intervention: Rationale and design of the randomized SORT OUT IX trial
111. Percutaneous coronary intervention for obstructive bifurcation lesions: the 14th consensus document from the European Bifurcation Club
112. Joint consensus on the use of OCT in coronary bifurcation lesions by the European and Japanese bifurcation clubs
113. Mechanical performance and healing patterns of the novel sirolimus-eluting bioresorbable Fantom scaffold: 6-month and 9-month follow-up by optical coherence tomography in the FANTOM II study
114. Intravascular ultrasound findings of the Fantom sirolimus-eluting bioresorbable scaffold at six- and nine-month follow-up: the FANTOM II study
115. Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study
116. Ten-year All-cause Mortality after Simple versus Complex Stenting of Coronary Artery Bifurcation Lesions in the Randomized Nordic Bifurcation Study
117. Two-year outcomes after revascularization with a biodegradable polymer ultra-thin strut sirolimus eluting stent and a biodegradable polymer biolimus-eluting stent. From the SORT OUT VII trial
118. TCT-10 Physiological testing of coronary artery stenosis by computation of invasive coronary angiography. The wire-free functional imaging (WIFI-II) study
119. Use of renal replacement therapy after out-of-hospital cardiac arrest in Denmark 2005–2013
120. Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysis
121. Ten-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segments
122. Percutaneous coronary intervention in left main coronary artery disease: the 13th consensus document from the European Bifurcation Club
123. Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial
124. CRT-600.05 Intravascular Ultrasound Findings of the Fantom Bioresorbable Scaffold at 6 and 9 Months Follow-up: Results from the Multicenter FANTOM II Study
125. Treatment of Bifurcation Lesions by Bail-Out TAP or Culotte: Lost in Translation?
126. P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction
127. Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents:5-Year Results From SORT OUT IV
128. Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H²⁴ Analysis
129. Renal Sympathetic Denervation in Treatment Resistant Essential Hypertension.:A Sham-Controlled, Double-blinded Randomized Trial (ReSET trial)
130. Association between socioeconomic factors and ICD implantation in a publicly financed health care system: a Danish nationwide study
131. Distance to invasive heart centre, performance of acute coronary angiography, and angioplasty and associated outcome in out-of-hospital cardiac arrest: a nationwide study
132. Meeting abstracts from the first European Emergency Medical Services congress (EMS2016)
133. TCT-29 Performance and healing patterns after implantation of a novel sirolimus eluting bioresorbable scaffold. Six-month follow-up by optical coherence tomography in the FANTOM II study
134. TCT-451 Two-year outcomes after revascularization with a biodegradable polymer ultra-thin strut sirolimus eluting stent and a biodegradable polymer biolimus-eluting stent. From the SORT OUT VII trial
135. TCT-321 Definite and probable stent thrombosis after revascularization with drug-eluting stents with a biodegradable polymer. From the randomized SORT OUT VII Trial
136. TCT-318 Ten-year All-cause Mortality after Simple versus Complex Stenting of Coronary Artery Bifurcation Lesions in the Randomized Nordic Bifurcation Study
137. Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction
138. Pre‐hospital administration of ticagrelor in diabetic patients with ST‐elevation myocardial infarction undergoing primary angioplasty: A sub‐analysis of the ATLANTIC trial.
139. Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine.
140. In memoriam Alfonso Medina Fernandez-Aceituno, MD, 1946-2017. Goodbye to a friend and to a 1,1,1 cardiologist
141. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients:the randomized diabetes and drug-eluting stent (DiabeDES) IV intravascular ultrasound trial
142. Vascular Response to Biolimus-eluting and Sirolimus-Eluting Stents in Patients with ST-segment Elevation Myocardial Infarction
143. 5-Year Outcome Of Zotarolimus-Eluting Versus Sirolimus-Eluting Coronary Stent Implantation In Patients With And Without Diabetes Mellitus
144. Short Versus Long-Term Clinical Outcomes In A Randomised Comparison Of Zotarolimus- and Sirolimus-Eluting Coronary Stents
145. Mechanisms of Incomplete Stent Apposition After Implantation of Drug-eluting Stents in patients with ST-segment Elevation Myocardial Infarction
146. Quality of Danish CPR courses for laypersons
147. Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention
148. Coronary bifurcation lesions treated with simple or complex stenting: 5-year survival from patient-level pooled analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study
149. INTERACTION BETWEEN MORPHINE AND TICAGRELOR IN THE ATLANTIC STUDY
150. Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.